Flagging announcement in DanCann Pharma A/S
COPENHAGEN, Denmark, 20 October 2021, DanCann Pharma A/S ("DanCann" or the "Company"), a Danish company powered by cannabinoids, hereby announces that the shareholder Xignotus Capital ApS’ (“Xignotus”) holding in the Company, as a result of the acquisition of CannGros ApS and the directed issue of units as of 05 October 2021 (“the Transactions”), has crossed the flagging limit of 25 percent.Prior to the Transactions, Xignotus’ holding in DanCann Pharma amounted to 25.62 percent of the votes and capital. Following the Transactions, Xignotus has now 21.65 percent of the votes and capital in